To The Moon

Some thoughts on today’s market rotation The market is showing an interesting divergence in premarket trading. Tech is starting to cool off, with weakness showing up across memory and AI infrastructure: $Micron Technology‌$美光科技(MU)$  ‌ $SanDisk($闪迪(SNDK)$  ‌ $SK hynix$SK海力士(SKHY)$  ‌ $Applied Optoelectronics‌$Applied Optoelectronics Inc.(AAOI)$  ‌ Meanwhile, healthcare names are quietly showing relative strength: $Regeneron‌$再生元制药公司(REGN)$  ‌‌‌ $Moderna‌$Moderna, Inc.(MRNA)$   This divergence is worth watchin

Things aren't looking great for U.S. consumers. Oil prices remain high (with supplies nearly depleted), GDP is lagging behind Big Tech (which is effectively carrying debt), and interest rates are high... It’s time to build up investment reserves 💵I’ve been saying this all along, though most people have likely already gone all-in 😅 📉 Walmart:  Walmart’s annual revenue grew by only 2.6%—well below the expected 3.8%—marking its weakest growth in six years. ‌$沃尔玛(WMT)$  ‌

Look closely. Behind this round of valuation recovery, there are actually 3 cold truths: 📉 Hardware gets de-rated, not downgraded NVIDIA’s forward P/E has been pushed down to around 25x, while revenue and earnings remain strong. The market still believes in AI it’s just no longer willing to pay unlimited premiums for hardware. 🚨 Software is entering a make-or-break phase AI applications still haven’t produced a true “killer app,” while computing costs continue to eat into margins. AI stories without real commercial traction are seeing their valuation bubbles squeezed out. 🔌 Capital is rotating into hard-core infrastructure Money is shifting from the Mag7 toward edge computing, custom chips, advanced packaging, power, and energy the more fundamental and essential layers of the AI infrastruc

MRNA’s ‌‌move higher today isn’t simply a reaction to the news it reflects the market beginning to reprice Moderna’s future. The success of Intismeran is giving investors a glimpse of Moderna’s potential to evolve from a vaccine company into a biotech with the value of a broader cancer-treatment platform‌$Moderna, Inc.(MRNA)$  

The thesis is playing out and I believe the next wave is just getting started‌$Applied Optoelectronics Inc.(AAOI)$  ‌‌$Lumentum Holdings Inc.(LITE)$  ‌$Coherent(COHR)$  ‌

AXTI has already delivered 100%+ gains, so I’ve taken some profits. I’ve already posted the next trade plan, with a target return of 30%. This time, I won’t let you down. Thank you all for your support. ‌$AXT Inc(AXTI)$  

The AI revolution has entered a new phase. The first wave was dominated by computing power — GPUs, accelerators, and HBM memory. However, as AI clusters scale to hundreds of thousands of GPUs, the next bottleneck is becoming clear: data movement. We believe optical communication is still in the early stages of a long-term growth cycle and will become one of the most important infrastructure layers supporting AI expansion.‌$Applied Optoelectronics Inc.(AAOI)$  ‌‌$Lumentum Holdings Inc.(LITE)$  ‌‌$Coherent(COHR)$  ‌